Specificity in the participation of connexin proteins in flow-induced endothelial gap junction communication

• Published in: Pflügers Archiv Vol. 465; no. 9; pp. 1293 - 1302
• Main Authors: Ebong, Eno E., DePaola, Natacha
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-09-2013; Springer Nature B.V
• Subjects: Biomedical and Life Sciences; Biomedicine; Cell Biology; Cell Communication; Cell Line; Cell Membrane - metabolism; Cell Proliferation; Connexins - metabolism; Endothelial Cells - metabolism; Endothelial Cells - physiology; Endothelium, Vascular - cytology; Gap Junctions - metabolism; Human Physiology; Humans; Molecular and Cellular Mechanisms of Disease; Molecular Medicine; Neurosciences; Nitric Oxide Synthase Type III - genetics; Nitric Oxide Synthase Type III - metabolism; Receptors; Stress, Mechanical; Cell proliferation; Gap junctional communication; Endothelial cells; Disturbed flow; Endothelial-type nitric oxide synthase
• ISSN: 0031-6768; 1432-2013
• DOI: 10.1007/s00424-013-1245-9

Endothelial cell (EC) dysfunction and atherosclerotic plaque formation coincide with human circulatory regions where blood flow is altered (disturbed). In areas of undisturbed uniform blood flow, including the majority of the vasculature, the vessel wall is relatively atherosclerotic lesion-resistant with normal endothelium. The molecular mechanisms of blood flow regulation of EC function and atherogenesis are unclear. We hypothesize that EC dysfunction potentiating atherosclerosis is related to disturbed flow (DF)-induced EC gap junctional intercellular communication (GJIC) changes via the gap junction connexin (Cx) 37, 40, and 43 proteins, which are involved in EC proliferation and vasoactivity that are known to be altered in atherosclerosis. We investigated human EC GJIC using an in vitro model of the hemodynamic features found in atherosclerotic-prone DF regions in vivo. Using dye transfer assays, Cx-specific mimetic peptide inhibitors, proliferation assays, and immunocytochemistry, we correlated functional GJIC via gap junction channels formed by hemichannels composed of the two most abundant endothelial Cx—Cx40 and Cx43—to EC proliferation and expression of vasoactive endothelial-type nitric oxide synthase (eNOS). We found that, in uniform flow conditions, substantial GJIC was conducted through gap junctions containing Cx40 hemichannels and correlated to a nonproliferative EC phenotype and membrane localization of eNOS, similar to physiological conditions. In DF, GJIC was largely attained through Cx43 hemichannel-containing gap junctions, EC phenotype was proliferative (attributed to loss of contact inhibition), and intracellular eNOS was more abundant than membrane eNOS, typical of atherosclerotic sites in vivo. This is the first in vitro study to demonstrate local hemodynamically defined Cx protein specificity in human EC GJIC with a potential role in endothelial dysfunction characteristic of early atherosclerosis.